Results 171 to 180 of about 6,613 (271)

Lansoprazole‐Induced Microscopic Colitis Mimicking Anticancer Drug‐Related Diarrhea During Lenvatinib and Pembrolizumab Combination Therapy: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Persistent diarrhea during anticancer therapy may not be attributable to anticancer agents. Our patient presented with diarrhea during lenvatinib–pembrolizumab therapy, likely caused by lansoprazole‐induced microscopic colitis. Even when symptoms closely resemble anticancer drug or immune‐related colitis, drug‐induced colitis due to ...
Shinichi Maruyama, Takuro Hirano, Kazuhiro Fuchinoue, Yoshikiyo Akasaka, Takanori Yoshida, Hiroshi Kanno, Masaru Kato   +6 more
wiley   +1 more source

Recommendations for Stress Ulcer Prophylaxis in Critically Ill Adults: A Contextualized Clinical Practice Guideline From the Saudi Critical Care Society and the Scandinavian Society of Anaesthesiology and Intensive Care Medicine, Endorsed by the Kuwait Anesthesia and Critical Care Society. [PDF]

Acta Anaesthesiol Scand
Amer M, Alhazzani W, Alshamsi F, Granholm A, Arabi YM, Olkkola KT, Rehn M, Al-Fares A, Alqahtani RM, Aljedai A, Alotaibi HF, Arafat A, AlMuhaidib S, Al Bshabshe A, Jalkanen V, Sigurðsson MI, Chew MS, Kalliomäki ML, Al-Dorzi HM, Alkhaldi F, Algethamy H, Almadi MA, Aldardeer N, Alhammad AM, Al-Omari A, Al-Suwaidan FA, Alshahrani M, Møller MH.   +27 more
europepmc   +1 more source

A Comparative Analysis of Short‐Term Outcomes of Off Pump Coronary Artery Bypass Grafting Alone or Simultaneous Cerebral Revascularization: A Single‐Center Retrospective Study

Clinical Cardiology, Volume 49, Issue 6, June 2026.
The final flowchart categorizes subjects into two groups: the control group (n = 60) undergoing OPCABG alone and the combined cardiocerebrovascular revascularization group (n = 57). ABSTRACT Objectives The impact of simultaneous coronary artery bypass grafting (CABG) with cerebral revascularization versus CABG alone on perioperative complications and ...
Bo Li, Qing‐Rui Fang, Bo‐Chen Yao, Qing‐Liang Chen, Jun‐Shan Li, Qiang Wang, Feng Zhao, Dong Wei, Dong‐Yan Yang, Jing Sun, Zhi‐gang Guo   +10 more
wiley   +1 more source

Inappropriate Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis in a Tertiary Care Hospital: A Cross-Sectional Study. [PDF]

Cureus
Alam S, Qureshi SI, Shakeel A, Javed A, Sami N, Ahmad B.   +5 more
europepmc   +1 more source

Standardized Management Pathway to Prevent Acute Rejection After Liver Transplantation Following ICI Therapy for Downstaging HCC

Health Care Science, Volume 5, Issue 3, Page 196-206, June 2026.
Findings indicate that within a standardized clinical pathway integrating structured immunosuppression, therapeutic drug monitoring, and early complication surveillance, liver transplantation after ICI exposure can be performed safely without increased rejection risk.
Ning Wang, Zebin Zhu, Hao Zheng, Can Qi, Xiaodong Yuan, Xuefeng Li, Zhijun Xu, Jiwei Qin, Wei Wu, Jizhou Wang, Ruipeng Song, Zhiyong Guo, Lianxin Liu, Shu‐Geng Zhang, Björn Nashan   +14 more
wiley   +1 more source

Stress ulcer prophylaxis practice in UK critical care units: A comparison of cross-sectional surveys between 2020 and 2024. [PDF]

J Intensive Care Soc
Borthwick M, Barton G, Boxall E, Dade JP, Farrell O, Forrest R, Graham-Clarke E, Kean D, Leigh H, Mehta R, Mulherron G, Roadley-Battin R, Sapsford D, Timmins A, Warburton J, Bourne RS.   +15 more
europepmc   +1 more source

An Updated Review and a Case Report: Stress Ulcer Prophylaxis. [PDF]

Cureus
Zhao JL, Tofani C, Infantolino A.
europepmc   +1 more source

Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study. [PDF]

J Pharm Pharm Sci
Ayhan YE, Eskidemir G, Koçoğlu Kınal AG, Aksoy N.   +3 more
europepmc   +1 more source

Audit on Practices of Stress Ulcer Prophylaxis in Intensive Care Unit Patients. [PDF]

Indian J Crit Care Med, 2020
Gupta D, Bhalotra AR, Singh R.
europepmc   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source